The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

There’s already been a mass exodus of investors as they gravitate towards the welcoming arms of New York, writes James Moore.

Victor Riparbelli, the chief executive and co-founder of Synthesia, claimed the UK and Europe had a “big problem” in securing ...

Guaranty Trust Holding Company Plc (GTCO) has successfully priced its fully marketed offering on the London Stock Exchange ...

Fundraising from initial public offerings in London has tumbled to its lowest level in at least 30 years, in a stark sign of ...

The bank’s non-performing loan ratio improved to 4.5 per cent during the period under review, down from 5.2 per cent at the ...

GTCO plans to raise $100m through a stock offering and fully list on the London Stock Exchange to support its growth strategy ...

Guaranty Trust Holding Company Plc (GTCO) says it will cancel the listing of its global depositary receipts (GDRs) on the ...

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate ...

AstraZeneca is reportedly considering moving its stock listing from London to the US, threatening a major hit to the FTSE 100 ...